Cargando…
E-cigarette or vaping product use-associated lung injury (EVALI) masquerading as COVID-19
SARS-CoV-2, the novel coronavirus causing COVID-19, has caused a global pandemic resulting in over 4 million deaths globally (data current as of 14 July 2021). E-cigarette or vaping product use-associated lung injury (EVALI) is a type of acute lung injury of unclear pathogenesis. The two pathologies...
Autores principales: | Ganne, Nandita, Palraj, Raj, Husted, Elizabeth, Shah, Ishan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311304/ https://www.ncbi.nlm.nih.gov/pubmed/34301688 http://dx.doi.org/10.1136/bcr-2021-243885 |
Ejemplares similares
-
E-CIGARETTE OR VAPING USE-ASSOCIATED LUNG INJURY (EVALI): EFFECTS OF VAPING OR COVID-19?
por: WALBRIDGE, GEORGE, et al.
Publicado: (2022) -
Suggested management of e-cigarette or vaping product use associated lung injury (EVALI)
por: Hage, René, et al.
Publicado: (2020) -
E-cigarette or Vaping Product Associated Lung Injury (EVALI) Presenting As Cardiac Arrest
por: Schekochikhina, Natalia, et al.
Publicado: (2022) -
Chemical Constituents Involved in E-Cigarette, or Vaping Product Use-Associated Lung Injury (EVALI)
por: Muthumalage, Thivanka, et al.
Publicado: (2020) -
E‐cigarette or vaping product use‐associated lung injury (EVALI) characterized by pulmonary ultrasound
por: Sacci, Peter, et al.
Publicado: (2020)